The Oncology Institute, Inc. TOI Capitated accounts receivable — Total Assets
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s capitated accounts receivable — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s capitated accounts receivable — total assets?
- The Oncology Institute, Inc. (TOI) reported capitated accounts receivable — total assets of $1.57M in Q1 2026.
- How has The Oncology Institute, Inc.'s capitated accounts receivable — total assets changed year-over-year?
- The Oncology Institute, Inc.'s capitated accounts receivable — total assets decreased by 59.6% year-over-year, from $3.88M to $1.57M.
- What does capitated accounts receivable — total assets mean?
- This metric measures the proportion of total assets tied up in accounts receivable specifically generated from capitated payment arrangements. It reflects the company's exposure to credit risk and the efficiency of its revenue cycle management within value-based care models. A higher ratio may indicate delayed collections or a significant reliance on fixed-fee reimbursement structures relative to the overall asset base.